http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110763650-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-3577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-3586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-3586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-3577
filingDate 2019-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110763650-B
titleOfInvention Metamaterial structure and method for enhancing norfloxacin terahertz weak signal
abstract The embodiment of the invention discloses a metamaterial structure and a method for enhancing norfloxacin terahertz weak signals, wherein the metamaterial structure comprises the following components: the third layer structure, the second layer structure and the first layer structure are sequentially and vertically arranged from the bottom upwards; the third layer structure is a metal gold layer; the second layer structure is a polyimide layer; the first layer structure comprises three four-opening square ring structures consisting of metal gold. The metamaterial structure for enhancing the norfloxacin terahertz weak signal provided by the embodiment of the invention is very sensitive to the surrounding environment, can show strong optical response even if the surrounding environment slightly changes, and can effectively enhance the norfloxacin terahertz weak signal through experimental verification, so that the norfloxacin weak content in a sample to be detected can be well predicted according to the terahertz time-domain spectrum of the sample to be detected attached to the metamaterial structure.
priorityDate 2019-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017038714-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702

Total number of triples: 25.